Xigduo

XIGDUO (dapagliflozin and metformin HCl) combines dapagliflozin (Forxiga), an SGLT2 inhibitor, and metformin, in a twice-daily tablet to improve glycaemic control in adult patients with Type 2 diabetes who are inadequately controlled by metformin alone.

Product Information – European Medicines Agency